Is Wegovy Available in the UK Right Now?

The biggest misconception: 'available' doesn't mean 'freely available'

A lot of people searching this question have already seen Wegovy mentioned in the press and assume it works like a pharmacy product you can simply pick up. That's not how it works. Wegovy is a Prescription-Only Medicine — semaglutide requires a clinical assessment before any supply. No legitimate pharmacy, online or on the high street, will dispense it without a prescriber signing off that it's suitable for you. A question our prescribers hear most weeks is whether someone can just buy it privately without going through a full consultation. They can't, and any seller suggesting otherwise is a serious red flag.

The MHRA has repeatedly warned about counterfeit weight-loss pens being sold online, including fakes that have contained insulin instead of the medicine claimed. If you're seeing Wegovy offered without clinical review or at prices far below the market, that's worth reporting at the MHRA Yellow Card portal. The right route is always a pharmacy you can verify on the GPhC register.

What Wegovy formats are now licensed in the UK?

This is genuinely moving quickly, which is part of why the question keeps being asked. The weekly injection pen has been available since 2023, starting at 0.25mg and titrating through 0.5mg, 1mg, 1.7mg and 2.4mg under a prescriber's direction. On 14 April 2026, the MHRA approved a dedicated single-dose 7.2mg pen, one injection per week, set for that dose, with a built-in needle that locks after use. That approval is for adults with a BMI of 30 or above only. Trials of the 7.2mg dose reported around 20.7% average weight loss over 72 weeks, narrowing the gap with tirzepatide.

Then, on 11 June 2026, the UK became the first country in Europe to license an oral GLP-1 medicine for weight management: the Wegovy tablet. It contains semaglutide and an absorption enhancer, taken once daily on an empty stomach first thing in the morning. The dose escalates from 1.5mg through 4mg and 9mg to a 25mg maintenance dose. The full Wegovy overview at nume covers both formats and what the clinical trial data looks like for each. Whether a specific dose or format is right for you is confirmed at consultation, not assumed beforehand.

Who qualifies, and what does the NHS vs private split look like?

The licensed eligibility criteria run like this: adults aged 18 or over with a BMI of 30 or above, or a BMI of 27–29.9 alongside at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. That's the private market licence.

The NHS pathway is considerably narrower. NICE's appraisal of semaglutide for weight management (TA875) recommends it only within specialist weight management services, for a maximum of two years, and for adults with a BMI of 35 or above (or 30–34.9 in certain circumstances) plus at least one weight-related comorbidity. Wales, Scotland and Northern Ireland apply different criteria. If fewer than 5% of body weight is lost after six months on the maintenance dose, continuing is reviewed. Waiting times through NHS specialist services can stretch considerably. If you're wondering whether Wegovy is available now and what that means in practice, that page goes into the detail on current NHS rollout timelines.

Private prescribing through a regulated online pharmacy sits outside the NHS structure entirely. There's no referral needed and no waiting list. You complete a clinical consultation, a prescriber reviews it the same day, and if you're suitable, treatment is dispatched. Our semaglutide information page explains the medicine's mechanism and evidence base in more depth. For a sense of what private treatment costs, the Wegovy pricing page gives an honest breakdown of what's included and what to watch for in low-headline prices elsewhere.

Is semaglutide available from any other source?

Semaglutide is also sold as Ozempic and as Rybelsus tablets, but both are licensed for type 2 diabetes, not weight management. It's worth being clear on this because Ozempic in particular gets mentioned frequently alongside Wegovy. They contain the same active ingredient at overlapping doses, but their licences are different and their approved uses in the UK are different. Prescribing Ozempic for weight loss off-label is possible but that's a separate clinical conversation. If you're on the titration schedule and want to understand what a 0.1 ml semaglutide dose means for your injection, that page explains exactly what that measurement looks like in practice. If you have questions about when Wegovy will be available in the UK and how supply timelines affect access, that page covers the current picture in full. Semaglutide for weight loss means Wegovy.

If you're looking at what treatment options exist beyond Wegovy, our weight management overview covers both Wegovy and Mounjaro (tirzepatide) side by side, including the evidence comparing the two. NHS England's guidance on weight management injections is also a reliable source if you want the official NHS framing of who these medicines are for. If you'd like to check your own eligibility and speak to a prescriber, starting a free consultation is the practical next step.